Current and Future MR Contrast Agents: Seeking a Better Chemical Stability and Relaxivity for Optimal Safety and Efficacy
- PMID: 32732647
- DOI: 10.1097/RLI.0000000000000710
Current and Future MR Contrast Agents: Seeking a Better Chemical Stability and Relaxivity for Optimal Safety and Efficacy
Comment on
-
Current and Future MR Contrast Agents: Seeking a Better Chemical Stability and Relaxivity for Optimal Safety and Efficacy.Invest Radiol. 2020 Sep;55(9):578-588. doi: 10.1097/RLI.0000000000000684. Invest Radiol. 2020. PMID: 32776767 Review.
References
-
- Lancelot E, Raynaud JS, Desché P. Current and future MR contrast agents—seeking a better chemical stability and relaxivity for optimal safety and efficacy. Invest Radiol. 2020;55:578–588.
-
- Spath NB, Thompson G, Baker AH, et al. Manganese-enhanced MRI of the myocardium. Heart. 2019;105:1695–1700.
-
- Gupta A, Caravan P, Price WS, et al. Applications for transition-metal chemistry in contrast-enhanced magnetic resonance imaging. Inorg Chem. 2020;59:6648–6678.
-
- Snyder EM, Asik D, Abozeid SM, et al. A class of FeIII macrocyclic complexes with alcohol donor groups as effective T1 MRI contrast agents. Angew Chem Int Ed Engl. 2020;59:2414–2419.
-
- Pellico J, Ellis CM, Davis JJ. Nanoparticle-based paramagnetic contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging. 2019;2019:1845637.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources